2021 Harvard Update in Clinical Cardiology
Wednesday, October 13, 2021
Introduction
Key Points in Evaluation and Medical Management of Coronary Artery Disease
Q&A Session
Pulmonary Embolism: Pathophysiology and Management Updates
Q&A Session
The Role of the Cardiologists in Diabetes Management
Q&A Session
Updates to Evaluate and Treat Adult Congenital Heart Disease
Q&A Session
Mitral Regurgitation: Timing of Intervention and choice between Surgery and Percutaneous Therapy
Q&A Session
Advances in Medical Treatment of Systolic Heart Failure
Advanced Heart Failure: Acute and Chronic Therapy
Q&A Session
Heart Failure with Preserved Ejection Fraction (HFpEF): 2021
Q&A Session
What’s New in Cardiac Markers
Q&A Session
Thursday, October 14, 2021
Introduction
Incorporating Advances in Electrical Therapy in Heart Failure for Improved Patient Outcomes
Q&A Session
Atrial Fibrillation: Pharmacologic and Nonpharmacologic Therapy
Q&A Session
Stroke Prevention in Atrial Fibrillation
Q&A Session
Supraventricular Tachycardia
Q&A Session
Dual Antiplatelet Therapy in Cardiovascular Disease
Q&A Session
Aortic Stenosis: Timing of Intervention and Choice Between Surgery and Percutaneous Therapy
Q&A Session
Thoracic Aortic Disease: Optimal Imaging and Management
Q&A Session
Hypertrophic Cardiomyopathy in 2021: Latest Concepts
Q&A Session
Acute Coronary Syndromes- STEMI and NSTEMI Latest Data
Q&A Session
Friday, October 15, 2021
Cardiovascular Care of Aging Athletes: Progress & Future Challenges
Q&A Session
How Exercise Protects the Heart
Q&A Session
Cardio-Oncology 2021
Q&A Session
Cardiovascular Disease and Pregnancy
Q&A Session
Coronary Disease: Medicate/Dilate/Operate
Q&A Session
COVID and Cardiovascular Disease
Q&A Session
Complex Coronary Artery Disease in the Cath Lab
Q&A Session
Dyslipidemia: Latest Concepts
Q&A Session
Cardiac Critical Care
Q&A Session
Closing Remarks
